Information Provided By: 
Fly News Breaks for February 8, 2017
CNC
Feb 8, 2017 | 07:41 EDT
UBS analyst A.J. Rice raised his price target on Centene to $80 from $73 following the company's Q1 earnings report. Q1 results are expected to be the lowest quarter due to seasonality, with consensus skewed to the second half of the year, he noted. The company was recently awarded a Pennsylvania TANF contract which could push the company toward the higher end of the range, said Rice, who reiterated his Buy rating on Centene shares.
News For CNC From the Last 2 Days
CNC
Apr 26, 2024 | 06:05 EDT
CNC
Apr 26, 2024 | 06:02 EDT
Reports Q1 revenue $40.41B, consensus $36.54B. "Centene's first quarter results demonstrate the strength of our diversified platform. We are pleased to raise full year 2024 guidance as we look to maximize the positive momentum being generated by our core businesses. We are executing against our strategic plans for growth and increasing access to affordable, high-quality healthcare for our members and the communities we serve," said Chief Executive Officer of Centene, Sarah M. London.
